SGLT2 Inhibitors versus Sulfonylureas as Add-On Therapy to Metformin in Type 2 Diabetes: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Umer, Muhammed
Salman, Ali
Nadeem, Shahrukh
Iqbal, Abiha
Tashrifwala, Fatema
Paryani, Neha Saleem
Ali, Eman
Kumar, Jai
Maniya, Muhammad Talha
Asad, Dayab
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Diabetes (Type II);
D O I：
10.1161/circ.148.suppl_1.14623
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14623
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EFFECT OF THIAZOLIDINEDIONES VERSUS SULPHONYLUREAS AS ADD-ON TREATMENTS TO METFORMIN IN TYPE 2 DIABETES MELLITUS:A META-ANALYSIS
    Setwiwattanakul, Wanwaree
    Poolsup, Nalinee
    Suksomboon, Naeti
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 38 (01) : 173 - 174
  • [42] Dose-dependent renoprotection efficacy of sglt2 inhibitors in type 2 diabetes: systematic review and network meta-analysis
    Hegde, Naveen C.
    Kumar, Ankit
    Patil, Amol N.
    Bhattacharjee, Samiksha
    Gamad, Nanda
    Kasudhan, Kripa Shanker
    Kumar, Vivek
    Rastogi, Ashu
    ACTA DIABETOLOGICA, 2023, 60 (10) : 1311 - 1331
  • [43] SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials
    Li, Wen-jie
    Chen, Xing-qing
    Xu, Ling-ling
    Li, Yuan-qing
    Luo, Bi-hui
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [44] Dose-dependent renoprotection efficacy of sglt2 inhibitors in type 2 diabetes: systematic review and network meta-analysis
    Naveen C. Hegde
    Ankit Kumar
    Amol N. Patil
    Samiksha Bhattacharjee
    Nanda Gamad
    Kripa Shanker Kasudhan
    Vivek Kumar
    Ashu Rastogi
    Acta Diabetologica, 2023, 60 : 1311 - 1331
  • [45] SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits
    Elisa Marilly
    Judith Cottin
    Natalia Cabrera
    Catherine Cornu
    Remy Boussageon
    Philippe Moulin
    Jean-Christophe Lega
    François Gueyffier
    Michel Cucherat
    Guillaume Grenet
    Diabetologia, 2022, 65 : 2000 - 2010
  • [46] Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Type 1 Diabetes: A Systematic Review and Meta-analysis
    El Masri, Dana
    Jaber, Linda
    DIABETES, 2017, 66 : LB41 - LB41
  • [47] SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits
    Marilly, Elisa
    Cottin, Judith
    Cabrera, Natalia
    Cornu, Catherine
    Boussageon, Remy
    Moulin, Philippe
    Lega, Jean-Christophe
    Gueyffier, Francois
    Cucherat, Michel
    Grenet, Guillaume
    DIABETOLOGIA, 2022, 65 (12) : 2000 - 2010
  • [48] Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes
    Clar, Christine
    Gill, James Alexander
    Court, Rachel
    Waugh, Norman
    BMJ OPEN, 2012, 2 (05):
  • [49] Efficacy and Safety of SGLT2i vs. Other Oral Antidiabetic Drugs as Dual Therapy Add-On to Metformin in Type 2 Diabetes-A Systematic Review and Meta-analysis
    Ma, Yuhang
    Lin, Yi
    Ding, Xiaoying
    Peng, Yongde
    DIABETES, 2024, 73
  • [50] The effect of SGLT2 inhibitors on kidney stones; a systematic review and meta-analysis
    Sisakht, Ali Rahnama
    Kamkar, Parvin
    Darzi, Mohammad Mehdi
    Madani, Mohammad Hamidi
    Arismani, Rasoul Jafari
    Gharebakhshi, Farshad
    Behi, Mahdi
    Mardanparvar, Hossein
    Haghighi, Ramin
    JOURNAL OF RENAL INJURY PREVENTION, 2024,
12345